- Home
- BBIO vs DRS Comparison
BBIO vs DRS Comparison
Compare BBIO & DRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- DRS
- Stock Information
- Founded
- BBIO 2015
- DRS 1969
- Country
- BBIO United States
- DRS United States
- Employees
- BBIO N/A
- DRS N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- DRS Military/Government/Technical
- Sector
- BBIO Health Care
- DRS Industrials
- Exchange
- BBIO Nasdaq
- DRS Nasdaq
- Market Cap
- BBIO 10.4B
- DRS 9.7B
- IPO Year
- BBIO 2019
- DRS N/A
- Fundamental
- Price
- BBIO $61.73
- DRS $35.15
- Analyst Decision
- BBIO Strong Buy
- DRS Strong Buy
- Analyst Count
- BBIO 18
- DRS 6
- Target Price
- BBIO $74.28
- DRS $46.83
- AVG Volume (30 Days)
- BBIO 2.7M
- DRS 1.4M
- Earning Date
- BBIO 10-29-2025
- DRS 10-29-2025
- Dividend Yield
- BBIO N/A
- DRS 1.02%
- EPS Growth
- BBIO N/A
- DRS 33.93
- EPS
- BBIO N/A
- DRS 0.99
- Revenue
- BBIO $353,780,000.00
- DRS $3,569,000,000.00
- Revenue This Year
- BBIO $123.32
- DRS $12.03
- Revenue Next Year
- BBIO $73.46
- DRS $6.76
- P/E Ratio
- BBIO N/A
- DRS $35.71
- Revenue Growth
- BBIO 62.46
- DRS 12.27
- 52 Week Low
- BBIO $21.72
- DRS $28.17
- 52 Week High
- BBIO $69.48
- DRS $49.31
- Technical
- Relative Strength Index (RSI)
- BBIO 59.65
- DRS 26.90
- Support Level
- BBIO $60.23
- DRS $34.50
- Resistance Level
- BBIO $64.44
- DRS $37.50
- Average True Range (ATR)
- BBIO 3.05
- DRS 1.11
- MACD
- BBIO 0.06
- DRS -0.42
- Stochastic Oscillator
- BBIO 53.68
- DRS 8.84
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About DRS Leonardo DRS Inc.
Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. The company is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.